
TG Therapeutics (NASDAQ:TGTX) brought in sales totaling $2.32 million during Q4 according to data provided by Benzinga Pro. However, earnings decreased 8.99%, resulting in a loss of $93.34 million. In Q3, TG Therapeutics brought in $2.03 million in sales but lost $85.64 million in earnings.